Table 1_The awakening effect of hyperbaric oxygen therapy combined with systematic auditor

89 comatose patients with severe traumatic brain injury were randomized in a prospective controlled trial. The dataset likely contains clinical scale scores (FOUR, GCS, CRS-R, GOS) and serum biomarker levels (S100B, NSE, BDNF) measured over 28 days and 3 months. The data was uploaded by Jie Li Rong to figshare in May 2026.

Use Cases

• Compare recovery trajectories based on FOUR, GCS, and CRS-R scores mentioned in the description.
• Analyze correlations between serum biomarker levels (S100B, NSE, BDNF) and functional outcomes (GOS).
• Evaluate the combined effect of hyperbaric oxygen therapy and systematic auditory stimulation on clinical outcomes.
• Assess patient/caregiver satisfaction outcomes related to a novel therapeutic regimen.

Strengths

• Data originates from a prospective randomized controlled trial with 89 patients.
• Includes multiple validated clinical assessment scales (FOUR, GCS, CRS-R, GOS) and serum biomarkers.
• Results show statistically significant differences (p < 0.001) between intervention and control groups for primary outcomes.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The trial lacked HBOT-only or SAS-only comparator arms, limiting conclusions on synergistic effects.

Provenance

Source

figshare, uploaded by Jie Li Rong.

Collection Method

Prospective randomized controlled trial.

Time Range

Trial period not specified; data covers measurements up to 3 months post-intervention.

Freshness

Last updated 2026-05-21 04:19:21; freshness should be verified.